Key result
Hemodialysis 2 times per week was associated with significantly higher odds of lower health-related quality of life compared to 3 times per week (aOR 1.71) among patients with end-stage kidney disease.
Why the study?
Health-related quality of life of patients with End-Stage Kidney Disease on hemodialysis is underappreciated in resource-limited countries.
Population
125 patients with End-Stage Kidney Disease on hemodialysis across five hospitals in Addis Ababa, Ethiopia
Design
Hospital-based cross-sectional study
Authors
Loading...
Supports HRQOL screening in ESKD on hemodialysis; hypothesis-generating for interventions targeting unemployment and dialysis frequency.
Cross-Sectional (n=125)
Yes
Odds Ratio: 1.71 (95% CI 1.07–3.83)
Absolute Event Rate: 56.4% vs 44.2%
p-value: p=0.04
Nearly half of ESKD patients on hemodialysis in Addis Ababa have low health-related quality of life, which is significantly associated with unemployment and receiving hemodialysis only twice a week.
Kim et al. (2021) conducted a cross-sectional in End Stage Kidney Disease (n=125). Hemodialysis 2 times per week vs. Hemodialysis 3 times per week was evaluated on Lower health-related quality of life (overall mean score ≤ 50) (aOR 1.71, 95% CI 1.07-3.83, p=0.04). Hemodialysis 2 times per week was associated with significantly higher odds of lower health-related quality of life compared to 3 times per week (aOR 1.71) among patients with end-stage kidney disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: